Becton Dickinson & Co. stock outperforms competitors on strong trading day
Becton Dickinson & Co. closed 3.20% below its 52-week high of $248.42, which the company achieved on March 28th.
Masimo taps Becton Dickinson executive Katie Szyman as CEO
Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after longtime CEO and founder Joe Kiani was ousted in a bitter proxy battle with ...
Leadership Success Story Of Abhijeet Bhardwaj's Revenue Re-Architecture Project At Becton Dickinson
Abhijeet Bhardwaj's commitment to technical excellence and innovation continues to drive successful outcomes in large-scale ...
Becton Dickinson EVP sells $120,000 in company stock
In a recent transaction, Shan David, Executive Vice President and Chief ISC Officer at Becton Dickinson & Co (NYSE:BDX), sold ...
Becton Dickinson, Biosero announce framework collaboration agreement
Becton, Dickinson and Company and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a ...
Jefferson nurses reported a defective IV needle and contributed to a national recall. Jefferson wants more staffers to report potential problems.
Paoletti, a charge nurse at Jefferson Torresdale Hospital, reported the problem internally, through the health system’s Great ...
Assembly Mag2d
Becton Dickinson Boosts U.S. Manufacturing of Critical Medical Devices
Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...
bovnews2d
Why Is Becton Dickinson and Co (BDX) Stock Surpassing 4.30% from Its 50-Day SMA?
Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $237.38 which represents a slight increase of $1.08 or 0.46% from the prior close of $236.3. The stock opened at $236.51 and ...
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors
Shares of Becton Dickinson & Co. BDX shed 1.02% to $237.92 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.61% to 6,086 ...
Becton Dickinson price target lowered to $278 from $312 at Barclays
Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...
Becton, Dickinson and Company's (NYSE:BDX) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Becton Dickinson's (NYSE:BDX) stock is up by 4.3% over the past month. As most would know, long-term fundamentals ...
Masimo taps Becton Dickinson executive Katie Szyman as CEO (Jan. 21)
(This Jan. 21 story has been corrected to fix the share price gain to 57% from 45% in paragraph 6) (Reuters) - Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device ...